Bone Marrow TransplantationTransplantation, HomologousGraft vs Host DiseaseWhole-Body IrradiationBone MarrowBone Marrow CellsAnemia, AplasticBusulfanLeukemiaTransplantation, AutologousHistocompatibility TestingGraft vs Host ReactionHematopoietic Stem Cell TransplantationCyclophosphamideTransplantation ConditioningStem CellsLiver TransplantationTransplantation ChimeraMethotrexateGraft SurvivalRecurrenceHematopoietic Stem CellsTissue DonorsHistocompatibilityStem Cell TransplantationCytomegalovirus InfectionsKidney TransplantationTransplantation, IsogeneicBone and BonesBone Marrow PurgingGraft RejectionHematologic NeoplasmsHematopoiesisImmunosuppressive AgentsCombined Modality TherapyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunosuppressionFollow-Up StudiesTreatment OutcomeLymphocyte DepletionLeukemia, Myeloid, AcuteMice, Inbred C57BLTime FactorsBone Marrow DiseasesRadiation ChimeraTransplantation ImmunologyHeart TransplantationAcute DiseaseRemission InductionT-LymphocytesSurvival AnalysisHLA AntigensPrecursor Cell Lymphoblastic Leukemia-LymphomaNuclear FamilyCyclosporineHepatic Veno-Occlusive DiseaseCell DifferentiationLung TransplantationRetrospective StudiesBone Marrow ExaminationLeukemia, MyeloidLeukocyte TransfusionLymphoma, Non-HodgkinColony-Forming Units AssayChimeraMyelodysplastic SyndromesOrgan TransplantationBone Marrow NeoplasmsSevere Combined ImmunodeficiencyGraft vs Tumor EffectHematologic DiseasesGraft vs Leukemia EffectActuarial AnalysisMesenchymal Stem Cell TransplantationCells, CulturedInfectionPeripheral Blood Stem Cell TransplantationEmbryonic Stem CellsCell TransplantationCord Blood Stem Cell TransplantationSurvival RateAntineoplastic Combined Chemotherapy ProtocolsFlow CytometryLymphocyte TransfusionCyclosporinsGranulocyte Colony-Stimulating FactorMice, Inbred BALB CSpleenAdult Stem CellsCarmustineAntigens, CD34Islets of Langerhans TransplantationCytarabineMelphalanPancytopeniaLeukocyte CountMultiple MyelomaHematopoietic Stem Cell MobilizationPancreas TransplantationSkin Transplantation